Practice Tips

PDF

Full colour PDF of the pages as they appeared in ‘best practice’.
 Printer friendly PDF.

New Health target

“Better help for smokers to quit” is one of the six health targets announced by the Minister of Health. The target is that 80% of hospitalised smokers will be provided with help and advice to quit by July 2010; 90% by July 2011, and 95% by July 2012. A similar target for primary care will be introduced by July 2010 through the PHO Performance Programme.

note

Best Practice tip: If you are arranging for a patient who smokes to be admitted to hospital it may be a good time to discuss quitting or at least temporary abstinence and prescribing of NRT.

Recent change to the Pharmaceutical Schedule

Bupropion
Bupropion hydrochloride is a dopamine-noradrenaline reuptake inhibitor that has demonstrated benefits when used in the treatment of nicotine dependence. When provided concomitantly with counselling, bupropion increases the chances of a quit attempt being successful.

Bupropion became available fully subsidised on the Pharmaceutical Schedule on July 1 2009 under the brand name Zyban.

Chemical Presentation Brand Pack size
Bupropion hydrochloride Tab modified-release 150 mg Zyban 30

Safe use of colchicine

Once again the Safe and Quality Use of Medicines group (SQM) reminds prescribers about the high risks associated with the use of colchicine. They have also identified a problem with outdated dosage recommendations on electronic discharge summaries from secondary care.

Colchicine should only be used for acute gout when there are no other alternative treatment options. Prescribe a minimal number of tablets only and ensure that the instructions for use are clearly understood by the patient and whānau.

  • Recommended dose: 2 x 0.5 mg initially, followed by 1 x 0.5 mg every six hours, up to a maximum of five tablets (2.5 mg) in the first 24 hours (or maximum of 1 mg if elderly, renal or hepatic impairment or less than 50 kg)
  • Do not exceed a cumulative oral dose of 12 tablets (6 mg) over four days. Wait for three days before administering further colchicine.
  • Check dose instructions received by patients discharged from secondary care

look See www.safeuseofmedicines.co.nz and BPJ 8 (Sept 2007) “A slow death from colchicine” and “Gout – hit the target: treatment of gout” for further information.

First void urine

Does first void urine (FVU) mean:

  1. First void urine of the day
  2. First part of the urine stream

If you answered “a” then you agree with 68% of surveyed GPs in Australia.
The correct answer is actually “b”.

FVU is an ambiguous and commonly misunderstood term. For effective chlamydia testing, it is important to get this right.

Reference: Lusk, J, Uddin R, Ferson M, et al. Primary health care providers surveyed commonly misinterpret ‘first void urine’ for chlamydia screening. Sex Health 2009;6(1):91-3.

Do you have a brilliant idea that you would like to share with your colleagues? Can you tell us about a mistake that you have learnt from so others don’t fall into the same trap? What’s new in primary care that people would want to know?

mail

Share your practice tips with us.
Email: editor@bpac.org.nz

Submit a comment about this article

Search bpac: Related articles: